Sofinnova Ventures Inc Buys Biomarin Pharmaceutical Inc, Merck Inc, Biogen Inc, Sells Spark Therapeutics Inc, Audentes Therapeutics Inc, Bristol-Myers Squibb Company

• New Purchases: MRK, BIIB, REGN, CCXI, SGEN, RYTM,
• Added Positions: BMRN, KRTX, PTCT, MRTX, NXTC, MGNX, MYOK, BCRX, FATE, VRTX, CALA, YMAB, KALA, OTIC,
• Reduced Positions: XLRN, HALO, TGTX, DERM, DRNA, FTSV, FOLD, ZYME, FIXX, SRPT, XBIT, HRTX, KDMN, UTHR, FOMX, ARQL,
• Sold Out: ONCE, BOLD, BMY, AGN, AMGN, NBIX, PFE, RETA, AIMT, AKBA, CYTK, ALGN, SNDX, PTLA, SVRA, SNSS,

For the details of Sofinnova Ventures Inc's stock buys and sells, go to https://www.gurufocus.com/guru/sofinnova+ventures+inc/current-portfolio/portfolio

1. Ascendis Pharma A/S (ASND) - 1,109,874 shares, 11.88% of the total portfolio.
2. NextCure Inc (NXTC) - 2,671,856 shares, 11.58% of the total portfolio. Shares added by 5.95%
3. Karuna Therapeutics Inc (KRTX) - 1,885,602 shares, 10.93% of the total portfolio. Shares added by 9.04%
4. Amarin Corp PLC (AMRN) - 5,208,305 shares, 8.59% of the total portfolio.
5. Natera Inc (NTRA) - 3,100,560 shares, 8.04% of the total portfolio.

Sofinnova Ventures Inc initiated holding in Merck & Co Inc. The purchase prices were between $81.3 and $91.74, with an estimated average price of $86.22. The stock is now traded at around $82.65. The impact to a portfolio due to this purchase was 1.69%. The holding were 240,806 shares as of .

Sofinnova Ventures Inc initiated holding in Regeneron Pharmaceuticals Inc. The purchase prices were between $274.13 and $376.51, with an estimated average price of $338.52. The stock is now traded at around $399.55. The impact to a portfolio due to this purchase was 1.45%. The holding were 50,086 shares as of .

Sofinnova Ventures Inc initiated holding in Biogen Inc. The purchase prices were between $220.06 and $304.07, with an estimated average price of $279.04. The stock is now traded at around $333.00. The impact to a portfolio due to this purchase was 1.45%. The holding were 63,711 shares as of .

Sofinnova Ventures Inc initiated holding in ChemoCentryx Inc. The purchase prices were between $6.89 and $39.55, with an estimated average price of $18.21. The stock is now traded at around $48.00. The impact to a portfolio due to this purchase was 1.15%. The holding were 376,944 shares as of .

Sofinnova Ventures Inc initiated holding in Seattle Genetics Inc. The purchase prices were between $79.97 and $121.62, with an estimated average price of $106.73. The stock is now traded at around $118.07. The impact to a portfolio due to this purchase was 0.44%. The holding were 50,000 shares as of .

Sofinnova Ventures Inc initiated holding in Rhythm Pharmaceuticals Inc. The purchase prices were between $19.53 and $25.5, with an estimated average price of $22.27. The stock is now traded at around $17.87. The impact to a portfolio due to this purchase was 0.04%. The holding were 21,319 shares as of .

Sofinnova Ventures Inc added to a holding in Biomarin Pharmaceutical Inc by 420.49%. The purchase prices were between $64.27 and $86.37, with an estimated average price of $75.94. The stock is now traded at around $89.01. The impact to a portfolio due to this purchase was 2.32%. The holding were 441,872 shares as of .

Sofinnova Ventures Inc added to a holding in PTC Therapeutics Inc by 80.02%. The purchase prices were between $33.65 and $50.07, with an estimated average price of $42.83. The stock is now traded at around $57.75. The impact to a portfolio due to this purchase was 0.85%. The holding were 517,092 shares as of .

Sofinnova Ventures Inc added to a holding in Mirati Therapeutics Inc by 251.89%. The purchase prices were between $70.76 and $128.86, with an estimated average price of $97.36. The stock is now traded at around $92.17. The impact to a portfolio due to this purchase was 0.77%. The holding were 108,383 shares as of .

Sofinnova Ventures Inc added to a holding in Macrogenics Inc by 101.85%. The purchase prices were between $7.95 and $12.27, with an estimated average price of $9.88. The stock is now traded at around $10.16. The impact to a portfolio due to this purchase was 0.49%. The holding were 1,173,882 shares as of .

Sofinnova Ventures Inc added to a holding in MyoKardia Inc by 71.93%. The purchase prices were between $50.92 and $74.6, with an estimated average price of $61.06. The stock is now traded at around $70.40. The impact to a portfolio due to this purchase was 0.46%. The holding were 195,871 shares as of .

Sofinnova Ventures Inc added to a holding in BioCryst Pharmaceuticals Inc by 316.30%. The purchase prices were between $1.59 and $3.45, with an estimated average price of $2.52. The stock is now traded at around $2.80. The impact to a portfolio due to this purchase was 0.43%. The holding were 2,151,164 shares as of .

Sofinnova Ventures Inc sold out a holding in Spark Therapeutics Inc. The sale prices were between $96.25 and $113.57, with an estimated average price of $107.51.

Sofinnova Ventures Inc sold out a holding in Audentes Therapeutics Inc. The sale prices were between $25.55 and $59.84, with an estimated average price of $37.91.

Sofinnova Ventures Inc sold out a holding in Bristol-Myers Squibb Company. The sale prices were between $49.21 and $64.19, with an estimated average price of $57.47.

Sofinnova Ventures Inc sold out a holding in Allergan PLC. The sale prices were between $165.4 and $191.58, with an estimated average price of $180.86.

Sofinnova Ventures Inc sold out a holding in Amgen Inc. The sale prices were between $189.21 and $243.2, with an estimated average price of $221.4.

Sofinnova Ventures Inc sold out a holding in Neurocrine Biosciences Inc. The sale prices were between $86.8 and $118.57, with an estimated average price of $105.21.